Antibody fragments pose unique challenges in recovery, purification, and formulation.
Jeffrey Shumway
Advertisement
Jeffrey Shumway is associate director, bioavailability enhancement at EMD Millipore, 290 Concord Road, Billerica, MA 01821.
Articles by Jeffrey Shumway
Advertisement
Latest Updated Articles
Downstream Purification and Formulation of Fab Antibody FragmentsPublished: January 1st 2014 | Updated:
Advertisement
Advertisement
Trending on BioPharm International
1
Why Flexibility and Commercial Viability Must Be Built-in Early for Scaling CGTs
2
How Rentschler Biopharma’s New Platforms Aim to Accelerate Biologics Development in Asia
3
Analyzing the Safety and Scope of Next-Generation Gene Editing Platforms
4
